Condition
Aortic Valve Failure
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
133%
4 of 3 completed with results
Key Signals
4 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed3
Terminated1
Active Not Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06510855Not ApplicableActive Not Recruiting
DurAVR™ THV EU-EFS
NCT05171712Not ApplicableCompleted
Portico and Navitor India Clinical Trial
NCT05666713Not ApplicableCompleted
NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial
NCT05002088Completed
Portico Valve-in-Valve Retrospective Registry
NCT04142658Phase 3Terminated
PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban
Showing all 5 trials